119 related articles for article (PubMed ID: 8010087)
1. Synergistic effect of probimane on anticancer cytotoxicity of doxorubicin in vitro.
Zhang Y; Ye QX; Liu J; Zhang ZY; Zhang TM
Zhongguo Yao Li Xue Bao; 1994 Jan; 15(1):56-9. PubMed ID: 8010087
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effect of dioxopiperazine compounds on malondialdehyde formation induced by doxorubicin in rat liver mitochondria in vitro.
Zhang Y; Hua HY; Zhang TM
Zhongguo Yao Li Xue Bao; 1993 Jul; 14(4):340-3. PubMed ID: 8249630
[TBL] [Abstract][Full Text] [Related]
3. Menadione reduced doxorubicin resistance in Ehrlich ascites carcinoma cells in vitro.
Xu CJ; Zhang Y; Wang J; Zhang TM
Zhongguo Yao Li Xue Bao; 1998 May; 19(3):273-6. PubMed ID: 10375743
[TBL] [Abstract][Full Text] [Related]
4. MST-16, a novel bis-dioxopiperazine anticancer agent, ameliorates doxorubicin-induced acute toxicity while maintaining antitumor efficacy.
Yoshida M; Maehara Y; Sugimachi K
Clin Cancer Res; 1999 Dec; 5(12):4295-300. PubMed ID: 10632373
[TBL] [Abstract][Full Text] [Related]
5. Relationships between the in vitro cytotoxicity and transport characteristics of pirarubicin and doxorubicin in M5076 ovarian sarcoma cells, and comparison with those in Ehrlich ascites carcinoma cells.
Nagai K; Nagasawa K; Sadzuka Y; Tsujimoto M; Takara K; Ohnishi N; Yokoyama T; Fujimoto S
Cancer Chemother Pharmacol; 2002 Mar; 49(3):244-50. PubMed ID: 11935217
[TBL] [Abstract][Full Text] [Related]
6. The role of a novel copper complex in overcoming doxorubicin resistance in Ehrlich ascites carcinoma cells in vivo.
Majumder S; Dutta P; Mookerjee A; Choudhuri SK
Chem Biol Interact; 2006 Feb; 159(2):90-103. PubMed ID: 16289015
[TBL] [Abstract][Full Text] [Related]
7. Synergistic anticancer effects of tetrandrine combined with doxorubicin or vincristine in vitro.
Sun AX; Ye ZG; Li CY; Xue BY; Li LF; Cao XF; Yang Q; Dai BQ
Zhongguo Yao Li Xue Bao; 1999 Jan; 20(1):69-73. PubMed ID: 10437129
[TBL] [Abstract][Full Text] [Related]
8. [Effects of bimolane and probimane on the incorporation of (3H)TdR, (3H)UR and (3H)Leu into Ehrlich ascites carcinoma cells iv vitro].
Wang MY; Liu TX; Li GD; Zhang TM
Zhongguo Yao Li Xue Bao; 1988 Jul; 9(4):367-9. PubMed ID: 3195348
[No Abstract] [Full Text] [Related]
9. Reversal effect of isotetrandrine, an isoquinoline alkaloid extracted from Caulis Mahoniae, on P-glycoprotein-mediated doxorubicin-resistance in human breast cancer (MCF-7/DOX) cells.
Wang TX; Yang XH
Yao Xue Xue Bao; 2008 May; 43(5):461-6. PubMed ID: 18717331
[TBL] [Abstract][Full Text] [Related]
10. Anti-proliferative effects, cell cycle G2/M phase arrest and blocking of chromosome segregation by probimane and MST-16 in human tumor cell lines.
Lu DY; Huang M; Xu CH; Yang WY; Hu CX; Lin LP; Tong LJ; Li MH; Lu W; Zhang XW; Ding J
BMC Pharmacol; 2005 Jun; 5():11. PubMed ID: 15963241
[TBL] [Abstract][Full Text] [Related]
11. Screening of biochemical modulator by tumor cell permeability of doxorubicin.
Sadzuka Y; Hatakeyama H; Daimon T; Sonobe T
Int J Pharm; 2008 Apr; 354(1-2):63-9. PubMed ID: 18054183
[TBL] [Abstract][Full Text] [Related]
12. Combined effects of buthionine sulfoximine and cepharanthine on cytotoxic activity of doxorubicin to multidrug-resistant cells.
Kisara S; Furusawa S; Murata R; Ogata M; Hikichi N; Takayanagi Y; Sasaki K
Oncol Res; 1995; 7(3-4):191-200. PubMed ID: 8555653
[TBL] [Abstract][Full Text] [Related]
13. [Reversal of adriamycin resistance by verapamil and ligustrazini in mouse Ehrlich ascites cancer].
Hu YP; Lin J; Wang QD; Yie QX; Zhang TM
Yao Xue Xue Bao; 1993; 28(1):75-8. PubMed ID: 8328276
[TBL] [Abstract][Full Text] [Related]
14. Reversal of doxorubicin resistance by tetrandrine in Chinese hamster ovary cell line.
He QY; Jiang B; Zhang HQ; Xue SB
Zhongguo Yao Li Xue Bao; 1992 Sep; 13(5):416-9. PubMed ID: 1300043
[TBL] [Abstract][Full Text] [Related]
15. [The antitumour activity of total saponin of Clematis chinensis].
Qiu G; Zhang M; Yang Y
Zhong Yao Cai; 1999 Jul; 22(7):351-3. PubMed ID: 12571931
[TBL] [Abstract][Full Text] [Related]
16. The antitumor effects of tetrodotoxin and/or doxorubicin on Ehrlich ascites carcinoma-bearing female mice.
El-Dayem SM; Fouda FM; Ali EH; Motelp BA
Toxicol Ind Health; 2013 Jun; 29(5):404-17. PubMed ID: 22317827
[TBL] [Abstract][Full Text] [Related]
17. Motexafin gadolinium: a redox active drug that enhances the efficacy of bleomycin and doxorubicin.
Miller RA; Woodburn KW; Fan Q; Lee I; Miles D; Duran G; Sikic B; Magda D
Clin Cancer Res; 2001 Oct; 7(10):3215-21. PubMed ID: 11595717
[TBL] [Abstract][Full Text] [Related]
18. Overcoming drug-resistant cancer by a newly developed copper chelate through host-protective cytokine-mediated apoptosis.
Mookerjee A; Mookerjee Basu J; Dutta P; Majumder S; Bhattacharyya S; Biswas J; Pal S; Mukherjee P; Raha S; Baral RN; Das T; Efferth T; Sa G; Roy S; Choudhuri SK
Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4339-49. PubMed ID: 16857809
[TBL] [Abstract][Full Text] [Related]
19. Reversal of doxorubicin resistance in multidrug resistant melanoma cells in vitro and in vivo by dipyridamole.
Desai PB; Duan J; Sridhar R; Damle BD
Methods Find Exp Clin Pharmacol; 1997 May; 19(4):231-9. PubMed ID: 9228648
[TBL] [Abstract][Full Text] [Related]
20. [Scavenging of probimane on semiquinone free radical formation by doxorubicin in rat heart].
Zhang Y; Zhang TM; Zhao BL; Han JK; Chen WC; Xin WJ
Zhongguo Yao Li Xue Bao; 1991 Jan; 12(1):20-3. PubMed ID: 1950578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]